Matthew J. Griffee

Matthew J. Griffee, MD is a Clinical Professor in the Department of Anesthesiology specializing in critical care medicine. His clinical expertise encompasses intensive care for cardiothoracic surgery patients (including coronary artery bypass grafting, valve replacement, and lung cancer surgery), ventricular assist device management, and ICU care for heart/lung transplant recipients. He holds board certifications from the American Board of Anesthesiology (including Critical Care Medicine subspecialty), American Board of Internal Medicine, and National Board of Echocardiography.

His educational background includes:

• Bachelor of Science in Cell Biology from the University of Washington
• MD from the University of Washington School of Medicine
• Internal Medicine Residency at the University of Utah
• Anesthesiology Residency at Oregon Health and Science University
• Critical Care Medicine Fellowship at Oregon Health and Science University (serving as Chief Resident)

Dr. Griffee's research centers on echocardiography-guided resuscitation for right heart failure and acute pulmonary hypertension, with significant contributions to cardiothoracic critical care. His work extends to advanced circulatory support systems and post-transplant critical care management, emphasizing real-time imaging techniques for hemodynamic optimization in high-acuity settings.

Analysis of his 15 most recent publications (2017-2024) reveals a dominant focus on critical care challenges during the COVID-19 pandemic, particularly neurological complications (stroke, long-term sequelae), thrombotic/hemorrhagic events, and ECMO applications. A consistent thread of echocardiography-guided interventions and resource utilization studies across international consortia demonstrates his subspecialty expertise in cardiothoracic critical care.

No scientific awards, prizes, or fellowships are documented in the available information.

There is no public record of graduate student advising or research grant funding. Dr. Griffee actively contributes to the COVID-19 Critical Care Consortium and ISARIC Clinical Characterization Group, participating in global observational studies and pandemic response protocols that have shaped critical care practices during public health emergencies.